Kidney Artery Blocking Treatment for Polycystic Kidney Disease
Part of Genetic & congenital, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study follows patients with a genetic kidney disease (autosomal dominant polycystic kidney disease) who are on dialysis and receive a procedure to block blood flow to their enlarged kidneys. Researchers will track how well the procedure works and how it affects patients over time using imaging scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 74 years old
- You have autosomal dominant polycystic kidney disease (a genetic condition causing multiple cysts to grow in the kidneys)
- Your kidneys are enlarged to a specific size (between 2000 and 5000 mL, roughly the size of grapefruits or larger)
- You are currently on dialysis (kidney-filtering treatment)
- You are scheduled to have or have recently had renal embolization (a procedure to block blood flow to the kidneys)
- You can safely undergo MRI scans (imaging tests) without contrast dye
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This pilot study tests whether a short-term diet can help people with autosomal dominant polycystic kidney disease (ADPKD). You would follow a special diet for one week to see how it affects your health.
This study tests whether changing what you eat can help reduce inflammation in your kidneys if you have ADPKD (a genetic kidney disease). Researchers will measure a specific protein in your urine to see if diet can slow kidney disease.
This study looks for early signs of high blood pressure in children and teens (12–17) who have a parent with ADPKD, a kidney condition. It uses non-invasive tests like blood pressure monitoring and MRI to track kidney health.
This study looks at people with autosomal dominant polycystic kidney disease to learn more about the condition. It is an observational study, meaning no new treatments are tested—just gathering information from your medical history and tests.
This study tests whether a common diabetes medication (SGLT2 inhibitor) can help people with autosomal dominant polycystic kidney disease (ADPKD) maintain kidney function longer. If you have fast-growing kidney cysts and are between 18 and 60 years old, this trial may be an option.
This study enrolls people who have been diagnosed with autosomal dominant polycystic kidney disease (ADPKD), a genetic kidney condition that can cause kidney cysts. It aims to learn about this specific form of the disease so better care is possible for the right patients.
Hear when a new Autosomal Dominant Polycystic Kidney Disease (ADPKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.